DACLATASVIR

UNII:	LI2427F9CI
Type:	INGREDIENT SUBSTANCE
Formula:	C₄₀H₅₀N₈O₆
Preferred Substance Name:	DACLATASVIR
InChIKey:	FKRSSPOQAMALKA-CUPIEXAXSA-N
GSRS Full Record:	LI2427F9CI i

1009119-64-5
BMS 790052
BMS-790052
CARBAMIC ACID, N,N'-((1,1'-BIPHENYL)-4,4'-DIYLBIS(1H-IMIDAZOLE-5,2-DIYL-(2S)-2,1-PYRROLIDINEDIYL((1S)-1-(1-METHYLETHYL)-2-OXO-2,1-ETHANEDIYL)))BIS-, C,C'-DIMETHYL ESTER
DACLATASVIR [MI]
DACLATASVIR [USAN]
DCV
DIMETHYL N,N'-((1,1'-BIPHENYL)-4,4'-DIYLBIS(1H-IMIDAZOLE-5,2-DIYL-((2S)-PYRROLIDINE-2,1-DIYL)((1S)-3-METHYL-1-OXOBUTANE-1,2-DIYL)))DICARBAMATE
Daclatasvir
Daclatasvir [WHO-DD]
EBP 883
EBP-883
daclatasvir [INN]
methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

DACLATASVIR

Synonyms and Mappings

Resources